Hepatitis E virus (HEV), primarily genotype 1 (HEV-1), causes approximately 20.1 million infections, 44000 deaths, and 3000 stillbirths annually. Current evidence indicates that HEV-1 is only transmitted in humans. Here, we evaluated whether Mongolian gerbils can serve as animal models for HEV-1 infection.
Risultati per: Sclerosi multipla e legame con il virus della mononucleosi
Questo è quello che abbiamo trovato per te
Influenza aviaria, c’è rischio di trasmissione su larga scala solo se il virus muta
Se i virus A/H5N1 acquisissero la capacità di diffondersi tra gli esseri umani potrebbe verificarsi una trasmissione su larga scala, ma a oggi la trasmissione da uomo a uomo non è mai stata confermata
Aviaria, rischio di trasmissione su larga scala se virus muta
Ecdc/Efsa, H5N1 ha già fatto passi verso l’adattamento ai mammiferi
Virus sinciziale, pediatri condividono linea ministero Salute
‘Disponibili a essere parte attiva’. Anticorpi per prevenirlo
Virus sinciziale, il ministero della Salute indica le misure di prevenzione
In una circolare. Secondo le raccomandazioni dell’Ecdc
Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart
Circulation, Ahead of Print. BACKGROUND:Viral infections can cause acute respiratory distress syndrome (ARDS), systemic inflammation, and secondary cardiovascular complications. Lung macrophage subsets change during ARDS, but the role of heart macrophages in cardiac injury during viral ARDS remains unknown. Here we investigate how immune signals typical for viral ARDS affect cardiac macrophage subsets, cardiovascular health, and systemic inflammation.METHODS:We assessed cardiac macrophage subsets using immunofluorescence histology of autopsy specimens from 21 patients with COVID-19 with SARS-CoV-2–associated ARDS and 33 patients who died from other causes. In mice, we compared cardiac immune cell dynamics after SARS-CoV-2 infection with ARDS induced by intratracheal instillation of Toll-like receptor ligands and an ACE2 (angiotensin-converting enzyme 2) inhibitor.RESULTS:In humans, SARS-CoV-2 increased total cardiac macrophage counts and led to a higher proportion of CCR2+(C-C chemokine receptor type 2 positive) macrophages. In mice, SARS-CoV-2 and virus-free lung injury triggered profound remodeling of cardiac resident macrophages, recapitulating the clinical expansion of CCR2+macrophages. Treating mice exposed to virus-like ARDS with a tumor necrosis factor α–neutralizing antibody reduced cardiac monocytes and inflammatory MHCIIloCCR2+macrophages while also preserving cardiac function. Virus-like ARDS elevated mortality in mice with pre-existing heart failure.CONCLUSIONS:Our data suggest that viral ARDS promotes cardiac inflammation by expanding the CCR2+macrophage subset, and the associated cardiac phenotypes in mice can be elicited by activating the host immune system even without viral presence in the heart.
Respiratory Virus Testing Does Not Necessarily Lower Antibiotic Use
In a meta-analysis, testing reduced antibiotic use in some test-positive patients, but not in patients overall.
Papilloma virus, allo studio un nuovo vaccino a forte risposta
Basato su Omvs ricombinanti, colma lacune prodotti precedenti
Covid, il virus può rimanere nell'organismo per oltre 1 anno
Studio apre prospettive sul Long Covid
New facet of CARs: HBV-specific CARs as inhibitors of virus morphogenesis and release
Although safe and effective vaccines against HBV (hepatitis B virus) are available, there are worldwide more than 2 billion people who had an HBV infection and about 250 million people suffering from chronic HBV infection. Chronic HBV infection is a major cause for liver diseases such as fibrosis, cirrhosis and hepatocellular carcinoma (HCC). It is estimated that about 800 000–1 000 000 people die each year due to the consequences of chronic HBV infection.1 Moreover, in almost all HBV-associated HCCs integrated HBV-DNA is found. Therapy options at present are limited and based on nucleoside/nucleotide analogues and interferon alpha. Since persistence of HBV infection frequently can be attributed to an insufficient cellular immune response approaches to rescue host immune response may help to eliminate infected cells and to suppress virus replication. A recent development are HBV-specific CARs (chimeric antigen receptors) human T-cells that are intended to recognise and eliminate HBV positive…
8 marzo: malata di sclerosi, il coraggio donne è esserci sempre
Chef umbra allettata ma continua a essere protagonista sui social
Virus sinciziale, nasce alleanza per proteggere bimbi
Disponibile profilassi con anticorpi monoclonali
8 marzo: le donne con sclerosi multipla discriminate
Aism lancia progetto “Cambia il finale”
Sclerosi multipla, al via la campagna 'Bentornata Gardensia'
Tornano a fiorire in 5mila piazze le piante per la ricerca
Hiv, malato libero dal virus da 5 anni dopo un trapianto di midollo
A 68 anni è il paziente più anziano ad aver avuto la remissione
Sclerosi multipla, sport come inclusione e benessere
Firmato protocollo Aism-Uisp